Sleep: Frequently Asked Questions

Sleep disorders affect an estimated 50 to 70 million adults in the United States, according to the American Academy of Sleep Medicine (AASM), making sleep medicine one of the most clinically significant yet underdiagnosed fields in modern healthcare. This page addresses the most frequently asked questions about sleep — from how professional diagnosis works to what a formal sleep study actually involves. The questions below cover the full scope of sleep health: regulatory context, clinical process, disorder classification, and common points of confusion that arise before and during care.

How do requirements vary by jurisdiction or context?

Sleep medicine operates under overlapping federal and state-level frameworks. At the federal level, the Centers for Medicare & Medicaid Services (CMS) sets coverage criteria for diagnostic tools such as polysomnography and home sleep testing, including specific apnea-hypopnea index (AHI) thresholds — an AHI of 15 or greater, or 5 or greater with documented symptoms, is required to qualify for CPAP coverage under CMS guidelines.

State medical boards govern licensure for sleep medicine physicians and registered polysomnographic technologists (RPSGTs), with credentialing standards maintained by the Board of Registered Polysomnographic Technologists (BRPT). Accreditation of sleep facilities follows standards published by the AASM, whose accreditation manual specifies room dimensions, equipment specifications, and staff-to-patient ratios.

Occupational contexts introduce additional requirements. The Federal Motor Carrier Safety Administration (FMCSA) addresses obstructive sleep apnea screening for commercial vehicle operators, and the Federal Aviation Administration (FAA) maintains separate protocols for pilots under 14 CFR Part 67. The economic impact of sleep loss extends these regulatory considerations into workplace safety domains as well.

What triggers a formal review or action?

A formal clinical review is typically triggered by one of three pathways: patient-reported symptoms meeting diagnostic screening thresholds, abnormal findings on a validated questionnaire, or referral from a primary care provider following a routine visit.

Validated instruments used as initial screening tools include the Epworth Sleepiness Scale (ESS), the STOP-BANG questionnaire for obstructive sleep apnea risk, and the Insomnia Severity Index (ISI). An ESS score of 11 or higher is considered indicative of excessive daytime sleepiness warranting further evaluation, per AASM clinical practice guidelines.

Employer-mandated reviews occur when occupational exposure to fatigue risk reaches regulatory thresholds — the National Transportation Safety Board (NTSB) has issued multiple recommendations linking operator fatigue to transportation incidents, prompting agency-level screening protocols. Safety-sensitive occupations governed by the Department of Transportation (DOT) follow 49 CFR Part 40 procedures when sleep disorder concerns arise during fitness-for-duty evaluations.

How do qualified professionals approach this?

Sleep medicine is a recognized subspecialty under the American Board of Medical Specialties (ABMS), with board certification administered through the American Board of Sleep Medicine (ABSM) and accessible via internal medicine, neurology, psychiatry, pulmonology, and otolaryngology pathways. Clinicians pursuing certification must complete a fellowship accredited by the Accreditation Council for Graduate Medical Education (ACGME).

A sleep specialist approaches evaluation in structured phases: symptom history, sleep diary review, validated questionnaire scoring, objective testing (in-lab or home-based), and differential diagnosis using criteria from the International Classification of Sleep Disorders, Third Edition (ICSD-3), published by the AASM.

Treatment selection draws on evidence-based clinical practice guidelines. For chronic insomnia disorder, Cognitive Behavioral Therapy for Insomnia (CBT-I) is designated as first-line treatment by both the AASM and the American College of Physicians (ACP). For moderate-to-severe obstructive sleep apnea, CPAP and positive airway pressure therapy remains the primary intervention supported by the highest tier of clinical evidence.

What should someone know before engaging?

Before pursuing a sleep evaluation, understanding the diagnostic pathway prevents delays. Primary care referral is the most common entry point, though direct access to sleep clinics is available in most states. Insurance pre-authorization is frequently required for in-lab polysomnography; CMS requires documented clinical necessity prior to approval.

Sleep diaries kept for a minimum of 2 weeks before the first appointment provide objective behavioral data that accelerates differential diagnosis. Wrist-worn actigraphy devices are sometimes requested prior to the formal visit for the same reason.

Patients with comorbid conditions — including cardiovascular disease, metabolic syndrome, or psychiatric diagnoses — should be aware that sleep and cardiovascular health, sleep and metabolic health, and sleep and mental health are bidirectionally linked. AASM clinical guidelines note that treating obstructive sleep apnea does not automatically resolve comorbid insomnia; both conditions often require independent treatment protocols.

Medication lists should be current at the time of the first visit. Certain antidepressants, beta-blockers, and corticosteroids directly affect sleep architecture and must be disclosed to ensure accurate interpretation of diagnostic data. A comprehensive overview of sleep medications is a useful reference before discussing pharmacological options with a clinician.

What does this actually cover?

Sleep medicine covers the diagnosis, treatment, and management of disorders affecting sleep initiation, maintenance, duration, timing, and quality. The ICSD-3 classifies sleep disorders into 6 primary categories:

1. Insomnia disorders — chronic, short-term, and other specified types (insomnia)
2. Sleep-related breathing disorders — including obstructive, central, and complex sleep apnea (sleep apnea)
3. Central disorders of hypersomnolence — including narcolepsy and hypersomnia
4. Circadian rhythm sleep-wake disorders — including delayed sleep phase and shift work disorder (circadian rhythm sleep-wake disorders)
5. Parasomnias — including REM sleep behavior disorder, sleepwalking, and night terrors (parasomnias, REM sleep behavior disorder)
6. Sleep-related movement disorders — including restless legs syndrome and periodic limb movement disorder

Coverage also extends to sleep health across the lifespan: sleep in children and adolescents, sleep in older adults, sleep during pregnancy, and infant and newborn sleep each present distinct clinical considerations and age-specific normative benchmarks.

What are the most common issues encountered?

The 4 most frequently encountered sleep disorders in clinical practice are obstructive sleep apnea (OSA), chronic insomnia disorder, restless legs syndrome (RLS), and circadian rhythm sleep-wake disorders — particularly delayed sleep phase disorder and shift work sleep disorder.

OSA affects an estimated 26% of adults aged 30 to 70 in the United States, according to data cited by the AASM, yet a substantial proportion remain undiagnosed. Chronic insomnia disorder affects approximately 10% of the adult population by ICSD-3 diagnostic criteria, though subclinical insomnia symptoms are reported by closer to 30% of adults in epidemiological surveys referenced by the National Center on Sleep Disorders Research (NCSDR).

Sleep deprivation effects represent a distinct and pervasive clinical concern separate from diagnosable disorders. Insufficient sleep syndrome — defined by the ICSD-3 as habitual sleep that is shorter than age-appropriate norms — is a behavioral condition rather than a disorder of sleep regulation, but produces comparable impairment in cognitive performance and immune function.

Shift work and sleep and jet lag represent occupationally and behaviorally driven disruptions to circadian timing that present frequently in primary care settings but are often misidentified as chronic fatigue or mood disorders.

How does classification work in practice?

Clinical classification follows the ICSD-3 framework, which requires symptom duration, frequency, and functional impairment criteria to be met before a formal diagnosis is assigned. Duration thresholds differ by disorder: chronic insomnia disorder requires symptoms present at least 3 nights per week for at least 3 months, while acute insomnia may be diagnosed with a shorter duration window.

For breathing-related disorders, classification is severity-based using the AHI: an AHI of 5 to 14 events per hour defines mild OSA; 15 to 29 defines moderate; and 30 or more defines severe, per AASM scoring manual criteria. Oxygen desaturation index (ODI) and arousal index data supplement AHI in determining treatment urgency.

The contrast between primary and secondary (comorbid) disorders is clinically significant. Under DSM-5 (American Psychiatric Association, 2013), sleep disorders that occur in the context of another mental disorder are classified separately from those presenting as independent conditions — a distinction that affects both treatment planning and insurance coding under ICD-10-CM.

Sleep disorder diagnosis criteria provides a detailed breakdown of the full ICSD-3 and DSM-5 classification structures. The foundational science underlying classification is grounded in understanding sleep stages and cycles and sleep architecture, both of which inform how scoring technologists and clinicians interpret polysomnographic data.

What is typically involved in the process?

The diagnostic and treatment process in sleep medicine follows a defined sequence with well-established decision points:

1. Initial screening — Validated questionnaires (ESS, STOP-BANG, ISI) administered in primary care or via direct intake. Sleep hygiene assessment is typically included.
2. Sleep diary and/or actigraphy — 2-week minimum period of objective behavioral tracking prior to formal evaluation.
3. Clinical evaluation — Full history, physical examination, and review of comorbidities with a board-certified sleep specialist.
4. Objective testing — In-lab polysomnography for complex presentations; home sleep testing for uncomplicated moderate-to-high OSA risk. AASM guidelines specify which presentations require in-lab versus portable monitoring.
5. Diagnosis and differential — ICSD-3 criteria applied to test results and clinical data. Multiple diagnoses can co-exist and each requires independent management.
6. Treatment initiation — CBT-I for insomnia, PAP therapy for OSA, pharmacological management per AASM clinical practice guidelines where indicated.
7. Follow-up and adherence monitoring — PAP therapy adherence is tracked via device data; CMS defines minimum adherence thresholds (4+ hours per night on 70% of nights over a 30-day period) for continued coverage.
8. Long-term management — Annual reassessment recommended; treatment adjustment based on symptom evolution and objective data.

The National Sleep Foundation and the AASM both publish public-facing guidance on recommended sleep durations by age, which serves as a normative reference throughout the process. A full overview of the sleep field — including ongoing developments in sleep science — is available through the sleep research and current science reference, while foundational context on the full scope of sleep health is accessible from the site index.

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)